Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Kota, Vidyasagar"'
Autor:
Rishabh Sharma, Jasdeep Kaur Gill, Caitlin Carter, Wajd Alkabbani, Manik Chhabra, Kota Vidyasagar, Feng Chang, Linda Lee, Tejal Patel
Publikováno v:
Biomedicine Hub, Vol 9, Iss 1, Pp 83-88 (2024)
Introduction: Older adults with dementia who are on multiple medications are more vulnerable to the use of potentially inappropriate medications (PIMs), which can significantly increase the risk of adverse events and drug-related problems. PIMs use i
Externí odkaz:
https://doaj.org/article/e32624e04ced42a28036b313c16913fa
Autor:
Kota, Vidyasagar1, Sahoo, Lulup Kumar1 lulupsahoo@gmail.com, Mishra, Ajit Prasad1, Panda, Adya Kinkar2, Veerapaneni, Hareen1, Dash, Devidutta1, Karan, Monica1
Publikováno v:
Annals of Indian Academy of Neurology. Nov/Dec2024, Vol. 27 Issue 6, p738-740. 3p.
Autor:
Santenna Chenchula, Kota Vidyasagar, Saman Pathan, Sushil Sharma, Madhav Rao Chavan, Akshaya Srikanth Bhagavathula, R. Padmavathi, M. Manjula, Manik Chhabra, Rupesh Gupta, Krishna Chaitanya Amerneni, Mohan Krishna Ghanta, Sofia Mudda
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-16 (2023)
Abstract A COVID-19 patient often presents with multiple comorbidities and is associated with adverse outcomes. A comprehensive assessment of the prevalence of comorbidities in patients with COVID-19 is essential. This study aimed to assess the preva
Externí odkaz:
https://doaj.org/article/90d2704fa0484576a91d4cfb1cd6eeec
Autor:
Akshaya Srikanth Bhagavathula, Cain C. T. Clark, Rishabh Sharma, Manik Chhabra, Kota Vidyasagar, Vijay Kumar Chattu
Publikováno v:
Health Promotion Perspectives, Vol 11, Iss 2, Pp 148-160 (2021)
Background: Several studies assessed the level of knowledge and general public behavior on human immunodeficiency virus/acquired immuno-deficiency syndrome (HIV/AIDS) in India. However, comprehensive scrutiny of literature is essential for any decisi
Externí odkaz:
https://doaj.org/article/b24d89d060fb4a90b2411ab43e3981e3
Autor:
Manik Chhabra, Kota Vidyasagar, Sai Krishna Gudi, Jatin Sharma, Rishabh Sharma, Muhammed Rashid
Publikováno v:
PLoS ONE, Vol 17, Iss 7, p e0269531 (2022)
Background and objectiveSaroglitazar is a newer antidiabetic agent approved to manage dyslipidemia. The objective is tevaluate the efficacy and safety profiles of saroglitazar in patients with dyslipidemia.MethodsA systematic search was conducted usi
Externí odkaz:
https://doaj.org/article/88ceb81af367422084338576301d4359
Autor:
Chenchula Santenna, Kota Vidyasagar, Krishna Chaitanya Amarneni, Sai Nikhila Ghanta, Balakrishnan Sadasivam, Saman Pathan, R. Padmavathi
Publikováno v:
Therapeutic Advances in Drug Safety, Vol 12 (2021)
Introduction: Remdesivir, an experimental antiviral drug has shown to inhibit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), both in vitro and in vivo . The present systematic review and meta-analysis were performed to quantify the saf
Externí odkaz:
https://doaj.org/article/57744051fff941af95dbece1e2974751
Autor:
Akshaya S. Bhagavathula, Kota Vidyasagar, Manik Chhabra, Muhammed Rashid, Rishabh Sharma, Deepak K. Bandari, Daniela Fialova
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Background: Older people often receive multiple medications for chronic conditions, which often result in polypharmacy (concomitant use of 5‒9 medicines) and hyperpolypharmacy (concomitant use of ≥10 medicines). A limited number of studies have b
Externí odkaz:
https://doaj.org/article/1b0685215ad04518b3454acb9a24b66f
Publikováno v:
Pharmaceuticals, Vol 14, Iss 10, p 991 (2021)
Tirzepatide is a novel once-a-week dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist, currently under trial to assess glycemic efficacy and safety in people with type 2 diabetes. A systematic review and me
Externí odkaz:
https://doaj.org/article/357640dbebbf451b88469932623b5895
Autor:
Rishabh Sharma, Manik Chhabra, Kota Vidyasagar, Muhammed Rashid, Daniela Fialova, Akshaya S. Bhagavathula
Publikováno v:
Pharmacy, Vol 8, Iss 4, p 219 (2020)
Background: Older patients with type 2 diabetes mellitus (T2DM) are at greater risk of receiving potentially inappropriate medications (PIM) during hospitalization which may result in adverse outcomes. Aim: To evaluate the extent of PIM use in the ol
Externí odkaz:
https://doaj.org/article/381a3a93034b42799692a614ed932631
Autor:
Akshaya Srikanth Bhagavathula, Benjamin Woolf, Jamal Rahmani, Kota Vidyasagar, Wubshet Tesfaye
Publikováno v:
Oncotarget
Recent studies have suggested a lower risk of hepatocellular carcinoma (HCC) in patients receiving selective serotonin reuptake inhibitors (SSRIs). The current study aimed to provide an updated and comprehensive assessment of the association between
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae7fd2c506b1d716f9db3a17dc694e89
https://doi.org/10.1007/s00228-021-03264-0
https://doi.org/10.1007/s00228-021-03264-0